본문 바로가기
KERD
논문KCI 등재

Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose Even though the therapeutic gold standard of hilar cholangiocarcinoma (HCCA) resection is cancer-free resection margin (RM), surgical treatment still remains challenging. This study evaluated the prognostic significance of RM status in resected HCCA patients and identified survival prognostic factors. Materials and Methods We reviewed records of 96 HCCA patients who underwent surgery from 2001 to 2012 and analyzed the RM status and prognostic factors that affecting survival. Results Negative RM (n=31, 33%) was significantly associated with better survival vs. positive RM (n=65, 67%) (mean survival time [MST], 33 months vs. 21 months; p=0.011). Margins with histological findings of non-dysplastic epithelium, low-grade dysplasia, and carcinoma in situ were not associated with survival differences (MST, 33 months vs. 33 months vs. 30 months; p=0.452), whereas positive margins were associated with poorer survival relative to carcinoma in situ (MST, 30 months vs. 21 months; p=0.050). Among patients with R0 resection, narrow ( 5 mm) and wide (> 5 mm) margins were not associated with survival differences (MST, 33 months vs. 30 months; p=0.234). Although positive proximal RM was associated with poorer survival compared to negative RM (MST, 19 vs. 33; p=0.002), no survival difference was observed between positive and negative distal RMs (MST, 30 vs. 33; p=0.628). Proximal RM positivity (hazard ratio [HR], 2.688; p=0.007) and nodal involvement (HR, 3.293; p < 0.001) were independent survival prognostic factors. Conclusion A clear RM, especially proximal RM status, was significant prognosticator, and proximal bile duct resection to the greatest technically feasible extent may be necessary, with careful consideration of the potential morbidity and oncologic outcomes after resection. However, an aggressive approach to obtain a negative distal RM might be controversial and should be considered carefully, depending on the patient's status.

Abstract

Purpose Even though the therapeutic gold standard of hilar cholangiocarcinoma (HCCA) resection is cancer-free resection margin (RM), surgical treatment still remains challenging. This study evaluated the prognostic significance of RM status in resected HCCA patients and identified survival prognostic factors. Materials and Methods We reviewed records of 96 HCCA patients who underwent surgery from 2001 to 2012 and analyzed the RM status and prognostic factors that affecting survival. Results Negative RM (n=31, 33%) was significantly associated with better survival vs. positive RM (n=65, 67%) (mean survival time [MST], 33 months vs. 21 months; p=0.011). Margins with histological findings of non-dysplastic epithelium, low-grade dysplasia, and carcinoma in situ were not associated with survival differences (MST, 33 months vs. 33 months vs. 30 months; p=0.452), whereas positive margins were associated with poorer survival relative to carcinoma in situ (MST, 30 months vs. 21 months; p=0.050). Among patients with R0 resection, narrow ( 5 mm) and wide (> 5 mm) margins were not associated with survival differences (MST, 33 months vs. 30 months; p=0.234). Although positive proximal RM was associated with poorer survival compared to negative RM (MST, 19 vs. 33; p=0.002), no survival difference was observed between positive and negative distal RMs (MST, 30 vs. 33; p=0.628). Proximal RM positivity (hazard ratio [HR], 2.688; p=0.007) and nodal involvement (HR, 3.293; p < 0.001) were independent survival prognostic factors. Conclusion A clear RM, especially proximal RM status, was significant prognosticator, and proximal bile duct resection to the greatest technically feasible extent may be necessary, with careful consideration of the potential morbidity and oncologic outcomes after resection. However, an aggressive approach to obtain a negative distal RM might be controversial and should be considered carefully, depending on the patient's status.

참고문헌 (16)

  1. Bismuth H, "Management strategies in resection for hilar cholangiocarcinoma", Ann Surg, 215, pp.31~38 (1992)
  2. Jarnagin WR, "Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies", Cancer, 98, pp.1689~1700 (2003)
  3. Dinant S, "The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma", HPB (Oxford), 7, pp.263~267 (2005)
  4. Kawahara R, "A case of postoperative recurrent hilar cholangiocarcinoma in the lower bile duct treated with pancreatoduodenectomy", Gan To Kagaku Ryoho, 41, pp.1518~1520 (2014)
  5. Geng XP, "Anatomy problems in the radical resection for hilar cholangiocarcinoma", Zhonghua Wai Ke Za Zhi, 47, pp.1167~1170 (2009)
  6. Shingu Y, "Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma", Surgery, 147, pp.49~56 (2010)
  7. Ribero D, "Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma", Ann Surg, 254, pp.776~781 (2011)
  8. Zaydfudim VM, "Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma", Am J Surg, 206, pp.159~165 (2013)
  9. Kondo S, "Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study", Ann Surg, 240, pp.95~101 (2004)
  10. Hemming AW, "Surgical management of hilar cholangiocarcinoma", Ann Surg, 241, pp.693~699 (2005)
  11. Hirano S, "Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality", J Hepatobiliary Pancreat Sci, 17, pp.455~462 (2010)
  12. Seyama Y, "Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate", Ann Surg, 238, pp.73~83 (2003)
  13. Shirai Y, "Intraoperative assessment of the resectability of hilar cholangiocarcinoma", Hepatogastroenterology, 59, pp.2436~2438 (2012)
  14. Murakami S, "Factors affecting survival after resection of intrahepatic cholangiocarcinoma", Surg Today, 44, pp.1847~1854 (2014)
  15. Ribero D, "Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients", Arch Surg, 147, pp.1107~1113 (2012)
  16. Konishi M, "Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma", Br J Surg, 97, pp.1363~1368 (2010)

관련 논문AI추천

Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System권재우, 김송철, 박예종, 송기병, 이우형, 이재훈, 이종우, 황대욱대한암학회 · Cancer Research and Treatment2020 · 제52권 제3호Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution권진이, 김규보, 김병혁, 방영주, 오도연, 장진영, 지의규, Sun-Whe Kim대한암학회 · Cancer Research and Treatment2017 · 제49권 제2호Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients김경식, 박경란, 박준성, 성진실, 윤동섭, 이우정, 이익재, 임정호대한암학회 · Cancer Research and Treatment2016 · 제48권 제2호Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma박광민, 성유나, 이영주, 이재훈, 전선영, 홍승모대한암학회 · Cancer Research and Treatment2019 · 제51권 제1호Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814)김규보, 김병혁, 김우철, 김진희, 김태규, 김태현, 박영희, 박혜진, 성진실, 신현수, 유정일, 임정호, 장아람, 정배권, 정원근, 지의규, 최진화대한암학회 · Cancer Research and Treatment2024 · 제56권 제1호Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis권진이, 김경수, 김규보, 지의규대한암학회 · Cancer Research and Treatment2017 · 제49권 제3호

이 간행물의 다른 논문 (39건)